BioNTech SE Overview

BioNTech SE Cost of Revenue

Cost of Revenue analysis for BNTX.

Quarterly Cost of Revenue

$195.87M

↑ 133.73% YoY

As of Mar 31, 2026

Annual Cost of Revenue (TTM)

$750.74M

↑ 32.57% YoY

Trailing 12 months ending Mar 31, 2026

Average Cost of Revenue (Comparison Companies)

Cost of Revenue History

Cost of Revenue Comparison

Annual Cost of Revenue Growth Rate (%)

Annual Cost of Revenue Growth (Absolute)

Jump to metric

Total Revenue Cost of Revenue Gross Profit Research & Development Selling, General & Admin Operating Income Other Income Expense Net EBIT Income Tax Net Income Profit Margin